Epitalon and Peptide Bioregulators: A Research Reference

Epitalon and Peptide Bioregulators: A Research Reference

Short peptide bioregulators form a distinct structural class within research peptide supply. Where most catalogued peptides run to a dozen residues or more, this group consists of tri- and tetrapeptides — chains of just three or four amino acids. That extreme brevity creates analytical characteristics quite unlike those of longer peptides, and is the most useful lens through which to understand the class.

This reference addresses structure, molecular identity and analytical method. No use of any kind is described.

Epitalon

Epitalon carries CAS registry number 307297-39-8, with molecular formula C14H22N4O4 and a molecular weight of approximately 390.4 g/mol. Its sequence is Ala-Glu-Asp-Gly — four residues, commonly abbreviated AEDG in single-letter notation.

The composition is worth reading carefully. Two of the four residues, glutamate and aspartate, carry acidic side chains. Alanine and glycine are the two smallest amino acids, neither carrying a functional side chain of note. There is no aromatic residue anywhere in the sequence.

Pinealon

Pinealon carries CAS registry number 175175-23-2, with molecular formula C15H26N6O8 and a molecular weight of approximately 418.4 g/mol. Its sequence is Glu-Asp-Arg — three residues, abbreviated EDR, and the compound is catalogued under both names.

Like Epitalon it contains glutamate and aspartate. The third residue, arginine, is strongly basic, giving Pinealon a mixed acidic-basic character that Epitalon lacks. Again there is no aromatic residue.

Why very short peptides are analytically awkward

The absence of aromatic residues in both compounds is the single most consequential analytical fact about this class. Peptide detection by ultraviolet absorbance relies on one of two things: aromatic side chains absorbing around 280 nm, or the peptide bond itself absorbing around 214 nm.

With no tryptophan, tyrosine or phenylalanine present, the 280 nm route is unavailable. That leaves 214 nm — but a tetrapeptide contains only three peptide bonds, and a tripeptide only two, so even that signal is weak relative to a longer chain of comparable mass. Detection sensitivity is correspondingly limited, and method development requires more care than for a peptide carrying a convenient chromophore.

A second complication is chromatographic retention. Reversed-phase HPLC separates on hydrophobicity, and small, highly polar molecules laden with charged side chains retain poorly on standard reversed-phase columns. Both these compounds are small and polar. Without adjusted method conditions they risk eluting at or near the void volume, where they are poorly resolved from salts, buffer components and other polar species.

Mass spectrometric considerations

At 390 to 420 g/mol these compounds sit at the low end of the peptide mass range and overlap with the mass region occupied by many common laboratory contaminants — plasticisers, detergent residues, solvent adducts. Interpreting a mass spectrum in this region requires more care than at higher masses where background is sparser.

The compounds ionise adequately, and the acidic side chains mean negative-mode electrospray is sometimes as informative as positive mode — a choice not usually worth considering for a strongly basic peptide.

Synthesis and purity

Very short peptides are straightforward to synthesise. A tetrapeptide requires three coupling steps; a tripeptide requires two. Deletion sequences, the dominant impurity class in long-chain synthesis, are far less prevalent simply because there are so few opportunities for a coupling to fail.

The impurity profile is consequently dominated not by truncated chains but by residual reagents, protecting-group fragments and salt content. Research-grade material of this type is typically specified at greater than 98% purity by HPLC, with the caveat that the method used must be one capable of retaining and resolving a small polar analyte in the first place.

Naming conventions in this class

Short bioregulator peptides are commonly catalogued under two or three names simultaneously, and the sequence abbreviation is frequently one of them. Pinealon appears as Pinealon, as EDR and as Glu-Asp-Arg — a trivial name, a single-letter sequence and a three-letter sequence, all describing the same tripeptide.

This is more helpful than it first appears. For a compound of three or four residues the sequence is short enough to serve as a complete structural description, so the abbreviation is not a shorthand for the name but a full specification of what the molecule is. For a 44-residue peptide no such convenience exists.

The caveat is that sequence abbreviations say nothing about terminal groups, salt form or stereochemistry. Two materials both correctly described as EDR could differ in whether the C-terminus is a free acid or an amide, and that difference would show in the mass.

Storage-relevant chemistry

Both compounds contain acidic side chains and, in Pinealon, a basic one. Peptides containing aspartate are subject to a well-characterised degradation route in which the aspartate side chain attacks the adjacent backbone, forming a cyclic intermediate that can subsequently open to give a rearranged product. The rate depends strongly on the residue following the aspartate and on conditions.

In the lyophilised state, with water largely absent and molecular mobility low, this chemistry proceeds slowly. It is nonetheless one of the reasons aspartate-containing peptides are supplied dry rather than in solution, and one of the reasons seal integrity matters.

Neither compound contains methionine, cysteine or tryptophan, so oxidation is a less prominent concern here than for sequences carrying those residues.

Documentation

Analytical documentation for a short bioregulator should state the batch identifier, the method used and the purity obtained. The method statement carries unusual weight for this class, because a standard reversed-phase method developed for larger peptides may simply fail to retain a small polar tripeptide well enough to resolve it from anything.

A purity figure produced by a method that does not properly retain the analyte is not a meaningful number, however high it appears.

Corix Labs supplies Epitalon 10mg and Pinealon 10mg as lyophilised research preparations with batch-level analytical documentation.

Corix Labs publishes analytical documentation for its research materials. See third-party testing reports for further detail on how batches are verified.

All materials referenced in this article are supplied strictly for laboratory research and analytical use. They are not licensed medicines and are not sold for use in humans or animals. Nothing in this article constitutes guidance on administration, preparation for use, or any clinical, therapeutic, diagnostic or cosmetic application.